/compare — side-by-sideLOADING
Valuation, growth, margins and forensic scores side-by-side — computed from each company's own SEC filings and last EOD close. No estimates, no fluff.
| Metric | CCELCRYO CELL INTERNATIO |
|---|---|
| Last close | $5.35close 2026-11-02 |
| Change % | +2.69%close 2026-11-02 |
| Market cap | $43Mclose 2026-11-02 |
| P/E | loss, no P/E |
| Revenue | $32M⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldRevenueFromContractWithCustomerIncludingAssessedTax As ofFY ending 2025-11-30 Filing10-K · 0001193125-26-083096 · filed 2026-02-27 Open the filing on EDGAR → |
Fundamentals from XBRL company facts (as filed); market cap & P/E use last EOD close. Each cell names its period. A ratio row reads not comparable when the companies’ periods differ by more than six weeks or mix a fiscal year with a trailing twelve months, and a figure more than a year older than the company’s newest period is marked older period. No row ranks the companies. Educational only, not investment advice.
| Rev growth (YoY) | -1.3%FY to 2025-11-30 |
| Net income | $-2429000⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldNetIncomeLoss As ofFY ending 2025-11-30 FilingDEF 14A · 0001193125-26-420608 · filed 2026-10-13 Open the filing on EDGAR →Open the XBRL payload →CiteCRYO CELL INTERNATIONAL INC (CCEL), us-gaap:NetIncomeLoss: -2,429,000 USD, fiscal year ended 2025-11-30. Form DEF 14A, accession 0001193125-26-420608, filed 2026-10-13. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0000862692/us-gaap/NetIncomeLoss.json |
| Net margin | -7.7%FY to 2025-11-30 |
| EPS (diluted) | $-0.30⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldEarningsPerShareDiluted As ofFY ending 2025-11-30 Filing10-K · 0001193125-26-083096 · filed 2026-02-27 Open the filing on EDGAR →Open the XBRL payload →CiteCRYO CELL INTERNATIONAL INC (CCEL), us-gaap:EarningsPerShareDiluted: -0.30 USD per share, fiscal year ended 2025-11-30. Form 10-K, accession 0001193125-26-083096, filed 2026-02-27. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0000862692/us-gaap/EarningsPerShareDiluted.json |
| Piotroski F-ScoreUNVALIDATED | 6FY to 2017-11-30, older period |
| Altman Z-ScoreUNVALIDATED | 0.97FY to 2017-11-30, older period |
| Beneish M-ScoreUNVALIDATED | inputs not filed |
| Next earnings | rep. 10-17 |